Drugs for Thyroid Cancer

Table. Drugs Prescribed for Thyroid Cancer

• Drug name (generic name)
• Drug company
• Indications
• Patient support services

Drug name (generic name)
• Armour Thyroid (thyroid tablets, USP)
Drug company
• AbbVie
Indications
• Treatment of thyroid cancer
Patient support services
• myAbbVie Assist Patient Assistance
  800-222-6885

Drug name (generic name)
• Cabometyx (cabozantinib) Tablets
Drug company
• Exelixis
Indications
• Treatment of patients 12 years or older with locally advanced or metastatic differentiated thyroid cancer that has progressed after previous VEGFR-targeted therapy and who are not eligible or are refractory to radioactive iodine therapy
Patient support services
• EASE Co-Pay Program
  844-900-3273
  
  EASE Patient Assistance Program
  844-900-3273

Drug name (generic name)
• Caprelsa (vandetanib) Tablets
Drug company
• Sanofi Genzyme
Indications
• Treatment of unresectable, locally advanced or metastatic medullary thyroid cancer
Patient support services
• Caprelsa Co-Pay Assistance Program
  800-367-4999
  
  Caprelsa Interim Access Program
  800-367-4999
  
  Caprelsa Patient Assistance Program
  800-367-4999

Drug name (generic name)
• Cometriq (cabozantinib) Capsules
Drug company
• Exelixis
Indications
• Treatment of progressive, metastatic medullary thyroid cancer
Patient support services
• EASE Co-Pay Program
  844-900-3273
  
  EASE Patient Assistance Program
  844-900-3273

Drug name (generic name)
• Gavreto (pralsetinib) Capsules
Drug company
• Genentech
Indications
• Treatment of patients 12 years or older with advanced or metastatic medullary thyroid cancer and RET mutation who require systemic therapy
  
  Treatment of patients 12 years or older with advanced or metastatic thyroid cancer and RET fusion who require systemic therapy and whose tumor is refractory to radioactive iodine
Patient support services
• Genentech Oncology Co-pay Assistance Program
  855-692-6729
  
  Genentech Patient Foundation
  888-941-3331

Drug name (generic name)
• Lenvima (lenvatinib) Capsules
Drug company
• Eisai
Indications
• Treatment of locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer
Patient support services
• Lenvima $0 Co-pay Program
  866-613-4724
  
  Lenvima Patient Assistance Program
  866-613-4724

Drug name (generic name)
• Mekinist (trametinib) Tablet
Drug company
• Novartis
Indications
• Treatment, in combination with Tafinlar, of unresectable or metastatic anaplastic thyroid cancer with a BRAF V600E mutation
Patient support services
• Novartis Oncology Universal Co-pay Program
  877-577-7756
  
  Novartis Patient Assistance Foundation
  800-277-2254

Drug name (generic name)
• Nexavar (sorafenib) Tablets
Drug company
• Bayer
Indications
• Treatment of locally recurrent or metastatic, progressive, differentiated thyroid cancer, refractory to radioactive iodine treatment
Patient support services
• Nexavar $0 Co-Pay Program
  647-245-5622
  
  Bayer US Patient Assistance Foundation
  866-228-7723
  
  Access Services by Bayer
  800-288-8374

Drug name (generic name)
• Retevmo (selpercatinib) Capsules
Drug company
• Eli Lilly
Indications
• Treatment of patients 12 years or older with advanced or metastatic medullary thyroid cancer and RET mutation who require systemic therapy
  
  Treatment of patients 12 years or older with advanced or metastatic thyroid cancer and RET fusion who require systemic therapy and whose tumor is refractory to radioactive iodine
Patient support services
• Retevmo Savings Card
  866-472-8663
  
  Lilly Cares Foundation Patient Assistance Program
  800-545-6962

Drug name (generic name)
• Synthroid (levothyroxine sodium tablets, USP)
Drug company
• AbbVie
Indications
• Treatment of thyrotrop-independent well-differentiated thyroid cancer, as an adjunct to surgery and radioiodine therapy
Patient support services
• Synthroid Co-pay Savings Card
  866-627-4980
  
  Synthroid Delivers Program
  844-438-7968
  
  myAbbVie Assist Patient Assistance
  800-222-6885

Drug name (generic name)
• Tafinlar (dabrafenib) Capsules
Drug company
• Novartis
Indications
• Treatment, in combination with Mekinist, of unresectable or metastatic anaplastic thyroid cancer with a BRAF V600E mutation
Patient support services
• Novartis Oncology Universal Co-pay Program
  877-577-7756
  
  Novartis Patient Assistance Foundation
  800-277-2254

Drug name (generic name)
• Thyrogen (thyrotropin alfa) injection
Drug company
• Sanofi Genzyme
Indications
• Adjunctive diagnostic tool for testing for well-differentiated thyroid cancer with previous thyroidectomy
  
  Adjunct treatment for radioiodine ablation of thyroid tissue remnants, after thyroidectomy for well-differentiated thyroid cancer
Patient support services
• Thyrogen Co-Pay Assistance Program
  888-497-6436
  
  The Thyrogen Patient Assistance Program
  888-497-6436

Drug name (generic name)
• Tirosint (levothyroxine sodium) Capsules
Drug company
• IBSA Pharma
Indications
• Treatment of thyrotropindependent well-differentiated thyroid cancer, as an adjunct to surgery and radioiodine therapy
Patient support services
• Tirosint Copay Savings Card
  833-666-2501
  
  Tirosint Patient Assistance Program
  833-838-3247
  
  Tirosint Direct Program
  833-666-2501